In Brief This Week: Sequenom; Promega; Danaher; Agilent; Horizon Discovery; Silicon Biosystems; Warnex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom this week said that the American Journal of Obstetrics and Gynecology has accepted for publication a manuscript that details the results of the firm's "locked-assay" study on its Trisomy 21 test. It did not provide a planned date for the article.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.